This study evaluates the effectiveness of a wise Intervention to reduce aggressive behaviors and promote prosocial behaviors toward LGB-TNB individuals among Spanish adolescents. Half of the participants will receive the experimental intervention, while the other half will receive a control intervention.
Age range
14 Years – 18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change from baseline in aggression scores toward LGB-TNB individuals, assessed using an adaptation of the Spanish version (Orue et al., 2018) of the Homophobic Bullying Scale (Prati, 2012).
Timeframe: Assessments were conducted at baseline and at 3, 6, and 9 months.
Change from baseline in online aggression scores toward LGB-TNB individuals, assessed using the Technology-Facilitated Gender- and Sexuality-Based violence (TFGSV; Martínez-Bacaicoa et al., 2023).
Timeframe: Assessments were conducted at baseline and at 3, 6, and 9 months.
Change from baseline in prosocial behavior scores toward LGB-TNB individuals through an ad hoc measure.
Timeframe: Assessments were conducted at baseline and at 3, 6, and 9 months.
Change from baseline in bystander intention scores when witnessing aggressive behavior toward LGB-TNB individuals.
Timeframe: Assessments were conducted at baseline, immediately after the intervention, and at 3, 6, and 9 months.